Implementation of Basal–Bolus Therapy in Type 2 Diabetes: A Randomized Controlled Trial Comparing Bolus Insulin Delivery Using an Insulin Patch With an Insulin Pen

Diabetes Technology and Therapeutics - United States
doi 10.1089/dia.2018.0298
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Mary Ann Liebert Inc

Related search

U-500 Insulin as a Component of Basal Bolus Insulin Therapy in Type 2 Diabetes

Diabetes Technology and Therapeutics
MedicineEndocrinologyMedical Laboratory TechnologyMetabolismDiabetes
2012English

Exenatide Add-On to Continuous Subcutaneous Insulin Infusion Therapy Reduces Bolus Insulin Doses in Patients With Type 2 Diabetes: A Randomized, Controlled, Open-Label Trial

Diabetes Therapy
Internal MedicineEndocrinologyMetabolismDiabetes
2016English

Multicenter Closed-Loop/Hybrid Meal Bolus Insulin Delivery With Type 1 Diabetes

Diabetes Technology and Therapeutics
MedicineEndocrinologyMedical Laboratory TechnologyMetabolismDiabetes
2014English

Premixed vs Basal-Bolus Insulin Regimen in Type 2 Diabetes: Comparison of Clinical Outcomes From Randomized Controlled Trials and Real-World Data

Diabetic Medicine
Internal MedicineEndocrinologyMetabolismDiabetes
2017English

The Relationships Between Glucose Variability and Renal Function in Type 2 Diabetes Patients on Basal-Bolus Insulin Therapy

Diabetes Mellitus
Internal MedicineEndocrinologyMetabolismDiabetes
2015English

Short-Term Cost-Effectiveness of Switching to Insulin Degludec in Japanese Patients With Type 2 Diabetes Receiving Basal–Bolus Therapy

Diabetes Therapy
Internal MedicineEndocrinologyMetabolismDiabetes
2019English

Diabetes Management and Healthcare Resource Use When Intensifying From Basal Insulin to Basal-Bolus: A Survey of Type 2 Diabetes Patients

Diabetes Therapy
Internal MedicineEndocrinologyMetabolismDiabetes
2018English

Basal-Bolus Insulin Therapy in Postoperative Inpatients With Diabetes Mellitus: Directions for Future Quality-Improvement Initiatives

Future Science OA
MedicineBiotechnology
2018English

Peri-Operative Management of Patients With Type-2 Diabetes Mellitus Undergoing Non-Cardiac Surgery Using Liraglutide, Glucose-Insulin-Potassium Infusion or Intravenous Insulin Bolus Regimens: A Randomised Controlled Trial

Anaesthesia
AnesthesiologyPain Medicine
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy